As a family-run business with its headquarters in Switzerland, Geistlich Pharma manufactures its biomaterials in its own production department. Geistlich works with ultra-modern machines and equipment, some of which have been specifically developed for this purpose, in order to safeguard the outstanding quality of the products and to drive innovations forward. Therefore the products meet the company’s own high standards, they undergo an elaborate manufacturing process. Geistlich proposal: masters the entire production chain and performs this in Switzerland. From the selection and control of the raw material to research and development and production to storage until dispatch, all steps are taken seamlessly and meet the company’s high standards of quality and safety.
Tested Swiss quality for the patient
Quality assurance has a decisive role here. Around five inspections a year are carried out by external regulatory authorities, including TÜV and the American Food and Drug Administration (FDA).
The strict norms and standards of the authorities are regularly met or exceeded by the company. Geistlich Pharma itself carries out 25 to 30 internal quality audits every year and audits around ten suppliers. To safeguard quality, Geistlich Pharma puts its faith in the continuous further training of its employees. Every year, 630 in-house training courses are held; 120 courses are held externally. After production, the products undergo numerous quality checks: 20 tests for the bone replacement materials and 25 for membranes. With all these measures, Geistlich Pharma AG is pursuing one goal: product quality and safety of the highest standard in order to improve patients’ quality of life.